Therefore, the present study examined the possibility that Ang II and CAD-MPs, activators of the local angiotensin pathway, affect the expression of SGLT1 and 2 in ECs and, if so, assessed their contribution to the induction of endothelial dysfunction. This evidence concerns the gene SLC5A1 and coronary artery disorder.